000 05483nam a22003975i 4500
999 _c88110
_d88110
_x1
001 88110
003 ES-MaUEC
005 20230207040623.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 161109s2016 gw | s |||| 0|eng d
020 _a9783319396583
024 7 _a10.1007/978-3-319-39658-3
_2doi
040 _aES-MaUEC
_bspa
_dES-MaUEC
050 4 _aQR177
_b2016 EB
245 0 0 _aEfflux-Mediated Antimicrobial Resistance in Bacteria :
_bMechanisms, Regulation and Clinical Implications
_cedited by Xian-Zhi Li, Christopher A. Elkins, Helen I. Zgurskaya.
260 _aCham
_bSpringer International Publishing
_bImprint: Adis
_c2016.
300 _a1 recurso en línea (XXI, 848 páginas)
_b72 ilustraciones, 61 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _aI-Bacterial drug efflux pumps: structures and transport mechanisms -- 1.Structures and transport mechanisms of RND efflux pumps -- 2.Structural and molecular landscape of MFS and MATE efflux pumps -- 3.Small multidrug resistance efflux pumps -- 4.Structures and transport mechanisms of the ABC efflux pumps -- 5.Multidrug efflux in the context of two-membrane cell envelopes -- II-Bacterial drug efflux pumps in antimicrobial resistance: substrates, regulation and clinical significance -- 6.Antimicrobial resistance in bacteria: an overview of mechanisms and role of drug efflux pumps -- 7.Antimicrobial drug efflux pumps in Staphylococcus aureus -- 8.Antimicrobial drug efflux pumps in other Gram-positive bacteria -- 9.Antimicrobial drug efflux pumps in Escherichia coli -- 10.Antimicrobial drug efflux pumps in Salmonella -- 11.Antimicrobial drug efflux pumps in Enterobacter and Klebsiella -- 12.Antimicrobial resistance and drug efflux pumps in Vibrio and Legionella -- 13.Antimicrobial resistance and drug efflux pumps in Acinetobacter -- 14.Antimicrobial drug efflux pumps in Pseudomonas aeruginosa -- 15.Antimicrobial drug efflux pumps in Stenotrophomona maltophilia -- 16.Antimicrobial drug efflux pumps in Burkholderia -- 17.Efflux pumps in Neisseria gonorrhoeae: contributions to antimicrobial resistance and virulence -- 18.Efflux pumps in Campylobacter: key players for antimicrobial resistance and environmental adaption -- 19.Antimicrobial resistance and drug efflux pumps in Helicobacter -- 20.Antimicrobial resistance and drug efflux pumps in Bacteroides -- 21.Efflux pumps in mycobacteria: antimicrobial resistance, physiological functions, and role in pathogenicity -- 22.Antimicrobial drug efflux genes and pumps in bacteria of animal and environmental origin -- 23.Role of plasmid-encoded drug efflux pumps in antimicrobial resistance -- 24.Influence of regulatory RNAs on antimicrobial resistance and efflux mechanisms -- III.Role of drug efflux pumps beyond antimicrobial resistance: natural functions -- 25.The relationship between bacterial multidrug efflux pumps and biofilm formation -- 26.Antimicrobial drug efflux systems as components of bacterial stress responses -- 27.Involvment of antimicrobial drug efflux systems in bacterial fitness and virulence -- IV. Antimicrobial development and efflux pump inhibitors -- 28.Impact of antimicrobial drug efflux pumps on antimicrobial discovery and development -- 29.Antimicrobial drug efflux pump inhibitors -- 30.Multidrug efflux pumps and their inhibitors characterized by computational modeling.
520 _aThis book, written by leading international experts, provides a comprehensive, current examination of transport-mediated antimicrobial resistance. As a particularly powerful mechanism of multidrug resistance, an in-depth examination of efflux pumps is conducted with bacteria of major public health concern including Enterobacteriaceae, Acinetobacter, Neisseria, Pseudomonas, staphylococci, and mycobacteria. The content spans structural biochemistry and transport mechanisms of the major transporter families and considers individual drug efflux systems across various Gram-positive and Gram-negative species. Genomic analysis of efflux pump distribution and their contribution to clinically-relevant resistance are a major focus of the text. Moreover, interplay between drug efflux pumps and other key resistance mechanisms such as intrinsic drug impermeability, inactivation, and target alterations are discussed, as well as their molecular expression-based regulation and physiological functions beyond resistance, involving biofilms, stress response, and pathogenicity. Finally, strategies are addressed to target this drug resistance mechanism with novel antimicrobials or drug inhibitor adjuvants.
988 _aEBOOK, EBSPRINGER
650 7 _aResistencia a los medicamentos
_2embne
_9146972
650 7 _9137892
_aMedicamentos
_2embne
700 1 _aLi, Xian-Zhi
_eeditor literario
_0Local
_9101552
700 1 _aElkins, Christopher A.
_eeditor literario
_9101553
_0Local
700 1 _aZgurskaya, Helen I.
_eeditor literario
_9101554
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-39658-3
_zUsuarios Universidad Europea
901 _ai9783319396583
907 _a.b1298114x
_b10-10-17
_c08-03-17
942 _2lcc
_cLE
945 _aQR177 .E345 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11602983
_z06-04-17
998 _b06/2019
_dz
_ea
_feng
_ggw
_h0